OspA L03 Group2: Difference between revisions
| Line 1: | Line 1: | ||
== '''OspA Protein''' == | == '''OspA Protein''' == | ||
<StructureSection load='1FJ1' size='500' side='right' caption='Structure of | <StructureSection load='1FJ1' size='500' side='right' caption='Structure of OspA (PDB entry [[1FJ1]])' scene=''> | ||
===Introduction=== | ===Introduction=== | ||
Lyme disease has been affecting many individuals year around developing chronic arthritis, neurologic and cardiac abnormalities, and skin lesions (Burgdorfer, 1982). The bacterial vector, Borrelia burgdorferi is spread through the bite and feeding of ticks bringing initial severe skin lesions, erythema chronicum migrans (Burgdorfer, 1982). Outer surface protein A, or OspA is found to inhibit bacterial transmission (Ding, 2000). Outer surface protein A, or OspA was found to initiate an immune response that contributed towards the development of Lyme disease vaccinations by preventing the transmission of Borrelia burgdorferi, the causative bacterial agent of Lyme disease after the attachment of an infected tick (Ding, 2000). Once entered the host through the skin or blood stream, Borrelia burgdorferi downregulated and suppressed OspA to minimize all of the host’s immunogenic characteristics (Rupprecht, 2008). When OspA on the spirochete migrated to an inflammatory environment, it induced apoptosis on the bacteria through the activation of B-cells (Rupprecht, 2008). Only OspA positive in borrelia bacteria were unable to establish an infection compared to OspA negative bacteria successfully hosted in studies of mice (Rupprecht, 2008). OspA known as a potent stimulator of neutrophils was able to kill the pathogen and attract leukocytes allowing the release of proinflammatroy cytokines in a host (Ruprecht, 2008) and avoid contracting Lyme disease as it affects the heart, joints, and nervous system (Rupprecht, 2008). | Lyme disease has been affecting many individuals year around developing chronic arthritis, neurologic and cardiac abnormalities, and skin lesions (Burgdorfer, 1982). The bacterial vector, Borrelia burgdorferi is spread through the bite and feeding of ticks bringing initial severe skin lesions, erythema chronicum migrans (Burgdorfer, 1982). Outer surface protein A, or OspA is found to inhibit bacterial transmission (Ding, 2000). Outer surface protein A, or OspA was found to initiate an immune response that contributed towards the development of Lyme disease vaccinations by preventing the transmission of Borrelia burgdorferi, the causative bacterial agent of Lyme disease after the attachment of an infected tick (Ding, 2000). Once entered the host through the skin or blood stream, Borrelia burgdorferi downregulated and suppressed OspA to minimize all of the host’s immunogenic characteristics (Rupprecht, 2008). When OspA on the spirochete migrated to an inflammatory environment, it induced apoptosis on the bacteria through the activation of B-cells (Rupprecht, 2008). Only OspA positive in borrelia bacteria were unable to establish an infection compared to OspA negative bacteria successfully hosted in studies of mice (Rupprecht, 2008). OspA known as a potent stimulator of neutrophils was able to kill the pathogen and attract leukocytes allowing the release of proinflammatroy cytokines in a host (Ruprecht, 2008) and avoid contracting Lyme disease as it affects the heart, joints, and nervous system (Rupprecht, 2008). | ||
| Line 9: | Line 9: | ||
====Functions==== | ====Functions==== | ||
</StructureSection> | </StructureSection> | ||
References: {{reflist}} | |||